MALVERN, Pa., March 16, 2022 /PRNewswire/ -- Reaction Biology ("Reaction" or the "Company"), an industry- leading provider of drug discovery services, today announced the closing of a significant ...
Discovery services contractor Reaction Biology has further expanded its executive team, framing the appointments as the next phase of the firm’s development. Reaction named Alan Findlater as chief ...
~ Bioassay GmbH, an Independent Contract Laboratory, Specializes in the Development, Validation and Routine Performance of Bioanalytical Assays ~ ~ Transaction Includes Acquisition of Bioassay GmbH ...
~ Transaction Expands Reaction Biology’s Capabilities to Provide Customers with Solutions in Both the Discovery and Development of New Drug Candidates ~ ~ Transaction Provides Vyant Bio with ...
MALVERN, Pa., Dec. 2, 2022 /PRNewswire/ -- Reaction Biology Corporation ("Reaction"), an industry-leading provider of drug discovery and development services, today announced that the Company has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results